Cargando…
6-Thioguanine and zebularine down-regulate DNMT1 and globally demethylate canine malignant lymphoid cells
BACKGROUND: The antimetabolite 6-thioguanine (6-TG) has been used to treat both human and canine lymphoid malignancies. 6-TG has been shown to be epigenetically active as a demethylating agent in a human lymphoma cell line, causing downregulation of DNA methyltransferase 1 (DNMT1) through ubiquitin-...
Autores principales: | Flesner, Brian K, Kumar, Senthil R, Bryan, Jeffrey N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272768/ https://www.ncbi.nlm.nih.gov/pubmed/25480665 http://dx.doi.org/10.1186/s12917-014-0290-8 |
Ejemplares similares
-
A Comparative Analysis of 5-Azacytidine- and Zebularine-Induced DNA Demethylation
por: Griffin, Patrick T., et al.
Publicado: (2016) -
Zebularine upregulates expression of CYP genes through inhibition of DNMT1 and PKR in HepG2 cells
por: Nakamura, Kazuaki, et al.
Publicado: (2017) -
Transcriptomics Analysis of the Tumor-Inhibitory Pathways of 6-Thioguanine in MCF-7 Cells via Silencing DNMT1 Activity
por: Li, Hao, et al.
Publicado: (2020) -
Toxicity and Clinical Trial of Azaserine and 6-Thioguanine in Advanced Solid Malignant Neoplasms
por: Schroeder, J. M., et al.
Publicado: (1964) -
Effect of 6-thioguanine on the stability of duplex DNA
por: Bohon, Jen, et al.
Publicado: (2005)